FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC

Clinical trial NCT05217069 · COMPLETED

Trial details

NCT number: NCT05217069
Sponsor: Ludwig-Maximilians - University of Munich
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment Related Cancer

Start date: 2019-09-27
Primary completion: 2023-09-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.